Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.
Burkhardt
Olaf
O
Thon
Simone
S
Burhenne
Jürgen
J
Welte
Tobias
T
Kielstein
Jan T
JT
D000368:Aged; D000818:Animals; D000935:Antifungal Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016638:Critical Illness; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000517:prevention & control*; D011743:Pyrimidines / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000628:therapy*; D014230:Triazoles / Q000493:pharmacokinetics / Q000627:therapeutic use*; D065819:Voriconazole; D047392:beta-Cyclodextrins / Q000097:blood*
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D047392:beta-Cyclodextrins; D065819:Voriconazole; C031215:betadex